Changeflow GovPing Healthcare & Life Sciences Revolution Medicines Trademark Renewal
Routine Notice Amended Final

Revolution Medicines Trademark Renewal

Favicon for changeflow.com USPTO Trademarks - Medical Services (Class 044)
Published
Detected
Email

Summary

The USPTO has renewed the trademark 'Revolution Medicines' (TM98222647) for pharmaceutical preparations and related services. The renewal is effective March 25, 2026, and covers services including drug discovery and providing medical information online.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document confirms the renewal of the USPTO trademark 'Revolution Medicines' (TM98222647), effective March 25, 2026. The trademark covers a range of services related to pharmaceutical preparations for oncological and immune system diseases, including drug discovery, research and development, and providing medical and health information via a website.

This is a routine trademark renewal and does not impose new regulatory obligations. Companies should ensure their own intellectual property portfolios are up-to-date and that they are not infringing on existing trademarks. No specific compliance actions are required based on this notice.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

REVOLUTION MEDICINES

Renewed TM98222647 Kind: renewed Mar 25, 2026

Abstract

Pharmaceutical preparations for the treatment of oncological and immune system related diseases and disorders; Pharmaceutical research and development; drug discovery services; providing information about medical and scientific research via a website; Providing medical information via a website; providing health information via a website; providing information to patients and healthcare professionals via a website relating to disease diagnosis, management, and treatment options in the field of oncological and immune system related diseases and disorders

Filing Date

2023-10-13

View original document →

Get daily alerts for USPTO Trademarks - Medical Services (Class 044)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM98222647

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Labeling Pharmaceutical Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Healthcare

Get alerts for this source

We'll email you when USPTO Trademarks - Medical Services (Class 044) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!